Akeso (HKEX: 09926) is a commercial-stage biopharmaceutical company committed to discovering, developing, manufacturing, and commercializing innovative medicines that address global medical needs. Since our inception, we have established a distinctive and integrated R&D innovation system with the comprehensive end-to-end drug development platform (ACE Platform) and bi-specific antibody drug development technology (Tetrabody) as the fundamental components, a GMP-compliant manufacturing system and a commercialization system with an advanced operation mode.
 
Akeso is actively developing a diverse pipeline of over 50 innovative assets in cancer, autoimmune disease, inflammation, metabolic disease, and other therapeutic fields. Among these, 19 assets have entered the clinical stage, with 3 innovative drugs already approved, and 13 pivotal/phase III trials ongoing. Utilizing its proprietary Tetrabody technology, Akeso has successfully developed the first-in-class PD-1/CTLA-4 bispecific antibody drug for the market. Additionally, the company has five other innovative bispecific antibody drugs in the clinical stage, including ivonescimab (PD-1/VEGF), PD-1/LAG-3, TIGIT/TGF-Beta, PD-1/CD73, and claudin18.2/CD47 bispecific antibodies.

Biotechnology

Pharmaceutical

Akeso Inc. 康方生物（9926.HK）

Akeso Inc. 康方生物（9926.HK）'s headquarters in 中山, China

This department focuses on developing and implementing clinical strategies to enhance healthcare outcomes and drive innovation.

Clinical Strategy

This department oversees the strategic management and implementation of commercial activities and initiatives.

Commercial Operations

This department manages employee relations, recruitment, and organizational development.

Human Resources

This department is responsible for overseeing medical strategies and engaging with healthcare professionals to ensure the accurate dissemination of medical information.

Akeso Inc. 康方生物（9926.HK）

Org chart

Teams

Clinical Strategy

Commercial Operations

Human Resources

Medical Affairs

Offices

Akeso Inc. 康方生物（9926.HK）

Org chart

Teams

Clinical Strategy

Commercial Operations

Human Resources

Medical Affairs

Offices

Related companies